Niphakis M, Cravatt B
Cell Chem Biol. 2024; 31(9):1636-1651.
PMID: 39303700
PMC: 11662599.
DOI: 10.1016/j.chembiol.2024.08.006.
Wu J, Chen Y, Wu J, Zhao D, Huang J, Lin M
J Cheminform. 2024; 16(1):13.
PMID: 38291477
PMC: 10829268.
DOI: 10.1186/s13321-023-00799-5.
Qin Y, Li D, Qi C, Xiang H, Meng H, Liu J
Acta Pharm Sin B. 2024; 14(1):319-334.
PMID: 38261830
PMC: 10793102.
DOI: 10.1016/j.apsb.2023.10.021.
Meyer C, McCoy M, Li L, Posner B, Westover K
Cell Rep Phys Sci. 2024; 4(10).
PMID: 38213501
PMC: 10783653.
DOI: 10.1016/j.xcrp.2023.101599.
Devkota R, Small J, Carbone K, Glass M, Vetere A, Wagner B
Diabetes. 2024; 73(4):585-591.
PMID: 38211571
PMC: 10958584.
DOI: 10.2337/db23-0506.
Target Class Profiling of Small-Molecule Methyltransferases.
Hanson Q, Hoxie N, Shen M, Guo H, Cho I, Chakraborty I
ACS Chem Biol. 2023; 18(4):969-981.
PMID: 36976909
PMC: 10983791.
DOI: 10.1021/acschembio.3c00124.
Inferring tumor-specific cancer dependencies through integrating ex vivo drug response assays and drug-protein profiling.
Batzilla A, Lu J, Kivioja J, Putzker K, Lewis J, Zenz T
PLoS Comput Biol. 2022; 18(8):e1010438.
PMID: 35994503
PMC: 9436053.
DOI: 10.1371/journal.pcbi.1010438.
Versatile small molecule kinase assay through real-time, ratiometric fluorescence changes based on a pyrene-DPA-Zn complex.
Kim J, Oh J, Han M
RSC Adv. 2022; 11(17):10375-10380.
PMID: 35423495
PMC: 8695712.
DOI: 10.1039/d1ra01547h.
Discovery of Novel and Highly Selective Cyclopropane ALK Inhibitors through a Fragment-Assisted, Structure-Based Drug Design.
Fujimori I, Wakabayashi T, Murakami M, Okabe A, Ishii T, McGrath A
ACS Omega. 2020; 5(49):31984-32001.
PMID: 33344853
PMC: 7745413.
DOI: 10.1021/acsomega.0c04900.
Targeting the Ubiquitin System in Glioblastoma.
Scholz N, Kurian K, Siebzehnrubl F, Licchesi J
Front Oncol. 2020; 10:574011.
PMID: 33324551
PMC: 7724090.
DOI: 10.3389/fonc.2020.574011.
Identification of MMP1 as a potential gene conferring erlotinib resistance in non-small cell lung cancer based on bioinformatics analyses.
Zhou H, Xiang Q, Hu C, Zhang J, Zhang Q, Zhang R
Hereditas. 2020; 157(1):32.
PMID: 32703314
PMC: 7379796.
DOI: 10.1186/s41065-020-00145-x.
Identification and characterization of the Cucurbitacins, a novel class of small-molecule inhibitors of Tropomyosin receptor kinase a.
Zhong Y, Xu H, Zhong Y, Zhang X, Zeng T, Li L
BMC Complement Altern Med. 2019; 19(1):295.
PMID: 31694615
PMC: 6836411.
DOI: 10.1186/s12906-019-2709-z.
A mechanistic evaluation of the angiogenic properties of a dehydrated amnion chorion membrane in vitro and in vivo.
McQuilling J, Burnette M, Kimmerling K, Kammer M, Mowry K
Wound Repair Regen. 2019; 27(6):609-621.
PMID: 31425636
PMC: 6900065.
DOI: 10.1111/wrr.12757.
Quantum capacitance-limited MoS biosensors enable remote label-free enzyme measurements.
Le S, Guros N, Bruce R, Cardone A, Amin N, Zhang S
Nanoscale. 2019; 11(33):15622-15632.
PMID: 31407757
PMC: 6792296.
DOI: 10.1039/c9nr03171e.
A non-covalent inhibitor XMU-MP-3 overrides ibrutinib-resistant Btk mutation in B-cell malignancies.
Gui F, Jiang J, He Z, Li L, Li Y, Deng Z
Br J Pharmacol. 2019; 176(23):4491-4509.
PMID: 31364164
PMC: 6932946.
DOI: 10.1111/bph.14809.
Advances in exploring the therapeutic potential of marine natural products.
Liang X, Luo D, Luesch H
Pharmacol Res. 2019; 147:104373.
PMID: 31351913
PMC: 6839689.
DOI: 10.1016/j.phrs.2019.104373.
Inhibition of Oncogenic Kinases: An In Vitro Validated Computational Approach Identified Potential Multi-Target Anticancer Compounds.
Ikram N, Mirza M, Vanmeert M, Froeyen M, Salo-Ahen O, Tahir M
Biomolecules. 2019; 9(4).
PMID: 30925835
PMC: 6523505.
DOI: 10.3390/biom9040124.
Kinase inhibitors: the road ahead.
Ferguson F, Gray N
Nat Rev Drug Discov. 2018; 17(5):353-377.
PMID: 29545548
DOI: 10.1038/nrd.2018.21.
Breakthroughs in modern cancer therapy and elusive cardiotoxicity: Critical research-practice gaps, challenges, and insights.
Zheng P, Li J, Kros J
Med Res Rev. 2017; 38(1):325-376.
PMID: 28862319
PMC: 5763363.
DOI: 10.1002/med.21463.
Entering the 'big data' era in medicinal chemistry: molecular promiscuity analysis revisited.
Hu Y, Bajorath J
Future Sci OA. 2017; 3(2):FSO179.
PMID: 28670471
PMC: 5481856.
DOI: 10.4155/fsoa-2017-0001.